Wayne Dimech examines the quality - or lack thereof - of SARS-Cov-2 testing. Wayne Dimech is Executive Manager, Scientific and Business Relations at NRL, Australia (NRL) in Melbourne. He is a recognized expert in infectious disease serology and laboratory quality.
Westgard QC is proud to announce the publication of the 2021 edition of Dr. Sharon S. Ehrmeyer's book, The Poor Lab's Guide to the Regulations.
We've talked about Westgard Rules for decades, and we've talked about Six Sigma for years. So what happens when we try to talk about both at the same time? Westgard Sigma Rules
Uncertainty in How to Calculate Measurement Uncertainty: Different approaches for incorporating effects of clinically significant bias
Funny thing about measurement uncertainty - it's not always clear how to calculate it. Particularly when clinically significant bias exists.
There may be 50 ways to leave your lover, but how many ways can you break the "Westgard Rules"? Can you guess? You may be surprised by the possibilities.
Standarization or Standarisation? Harmonization or Harmonisation? We seem to be headed toward a schism in performance specifications, rather than a consensus. Here's a current comparison of Global Performance Specifications for Chemistry Assays.
By mid-October 2020, the list of methods for SARS-COV-2 testing (molecular, antigen, rapid, and serology), broke the 870 mark. Rather than ask laboratories to evaluate more than 870 possibilities, we've narrowed the candidates down to a short list.